These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 28302152)

  • 1. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
    Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
    BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury.
    Salie R; Huisamen B; Lochner A
    Cardiovasc Diabetol; 2014 Jul; 13():109. PubMed ID: 25197961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
    Lochner A; Genade S; Moolman JA
    Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain free fatty acids inhibit ischaemic preconditioning of the isolated rat heart.
    Lochner A; Genade S; Genis A; Marais E; Salie R
    Mol Cell Biochem; 2020 Oct; 473(1-2):111-132. PubMed ID: 32602016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial triggers involved in activation of remote ischaemic preconditioning.
    Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
    Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of preconditioning on post-ischaemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts.
    Efstathiou A; Seraskeris S; Papakonstantinou C; Aidonopoulos A; Lazou A
    Eur J Cardiothorac Surg; 2001 Apr; 19(4):493-9. PubMed ID: 11306319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance.
    Wensley I; Salaveria K; Bulmer AC; Donner DG; du Toit EF
    Exp Physiol; 2013 Nov; 98(11):1552-64. PubMed ID: 23851919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity.
    Maarman G; Marais E; Lochner A; du Toit EF
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):205-16. PubMed ID: 22407171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
    Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
    Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the washout period in preconditioning.
    Salie R; Lochner A; Loubser DJ
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart--a protective additive to ischaemic preconditioning.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Feb; 29(2):269-74. PubMed ID: 7736505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart.
    Vasara E; Katharou I; Lazou A
    Clin Exp Pharmacol Physiol; 2003; 30(5-6):350-6. PubMed ID: 12859425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
    Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
    Salie R; Moolman JA; Lochner A
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart.
    Cave AC; Collis CS; Downey JM; Hearse DJ
    Cardiovasc Res; 1993 Apr; 27(4):663-8. PubMed ID: 8324802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.